Capital World Investors
BHVN icon

Capital World Investors’s Biohaven BHVN Stock Holding History

Capital World Investors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250,000
Closed -$2.82M – 626
2025
Q4 		$2.82M Hold
250,000
– – ﹤0.01% 533
2025
Q3 		$3.75M Hold
250,000
– – ﹤0.01% 524
2025
Q2 		$3.53M Hold
250,000
– – ﹤0.01% 524
2025
Q1 		$6.01M Hold
250,000
– – ﹤0.01% 497
2024
Q4 		$9.34M Hold
250,000
– – ﹤0.01% 481
2024
Q3 		$12.5M Hold
250,000
– – ﹤0.01% 464
2024
Q2 		$8.68M Sell
250,000
-170,950
-41% -$6.76M ﹤0.01% 468
2024
Q1 		$23M Hold
420,950
– – ﹤0.01% 448
2023
Q4 		$18M Hold
420,950
– – ﹤0.01% 449
2023
Q3 		$10.9M Hold
420,950
– – ﹤0.01% 463
2023
Q2 		$10.1M Hold
420,950
– – ﹤0.01% 459
2023
Q1 		$5.75M Hold
420,950
– – ﹤0.01% 473
2022
Q4 		$5.84M Buy
+420,950
New +$5.94M ﹤0.01% 492

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors's BHVN Position: Q1 2026 in Review

Capital World Investors sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 250,000 shares — an estimated $2.82M sold.

Capital World Investors first reported a position in BHVN in Q4 2022 and held it in 13 quarters. The position peaked at $23M in Q1 2024. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Capital World Investors reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Capital World Investors sold 250,000 Biohaven shares in Q1 2026, an estimated $2.82M.
  • Capital World Investors first reported a position in Biohaven in Q4 2022 and held it in 13 quarters.
  • Capital World Investors's Biohaven position peaked at $23M in Q1 2024.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.